Related Experiment Video

Updated: May 24, 2026

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

Nitric oxide in primary ciliary dyskinesia

Woolf T Walker1, Claire L Jackson, Peter M Lackie

  • 1Primary Ciliary Dyskinesia Diagnostic and Research Team (MP 803) NIHR Respiratory Biomedical Research Unit, Southampton University Hospitals NHS Trust, Tremona Road, Southampton, SO16 6YD, UK.

The European Respiratory Journal
|March 13, 2012
PubMed

Insights

Nasal nitric oxide is significantly reduced in primary ciliary dyskinesia (PCD), a condition causing recurrent infections. Research explores the mechanisms behind low nitric oxide levels and potential therapeutic benefits.

Area of Science:

  • Respiratory Medicine
  • Biochemistry
  • Genetics

Background:

  • Nitric oxide (NO) is synthesized in respiratory epithelium and increases with infection/inflammation.
  • Primary ciliary dyskinesia (PCD) involves impaired mucociliary clearance, leading to recurrent sinopulmonary infections.
  • Nasal NO levels are markedly reduced in PCD patients, serving as a diagnostic screening tool, though mechanisms remain unclear.

Purpose of the Study:

  • To review nitric oxide (NO) synthesis, release, and measurement in the upper airways, focusing on Primary ciliary dyskinesia (PCD).
  • To explore hypotheses explaining reduced nasal NO levels in PCD.
  • To consider the potential benefits of augmenting airway NO levels in PCD and related conditions.

Main Methods:

  • Literature review of epithelial nitric oxide (NO) synthesis, release, and measurement.
  • Analysis of proposed hypotheses for low NO in Primary ciliary dyskinesia (PCD).
  • Evaluation of potential therapeutic strategies involving NO augmentation.

Main Results:

  • Nasal nitric oxide (NO) levels are consistently low in Primary ciliary dyskinesia (PCD) patients despite chronic infections.
  • Several hypotheses exist for the reduced NO, but underlying mechanisms require further elucidation.
  • NO augmentation may not benefit common PCD but could help secondary dyskinesias and bacterial infections, especially those involving biofilms.

Conclusions:

  • Further research is essential to clarify NO biosynthesis in the respiratory epithelium of PCD patients and the role of paranasal sinus anatomy.
  • While NO augmentation may not be a primary treatment for typical PCD, it shows potential for secondary dyskinesias and biofilm-associated infections.

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency11:13

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency

Published on: November 10, 2021

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Mechanism of Ciliary Motion01:05

Mechanism of Ciliary Motion

The ciliary structures were first seen in 1647 by Antonie Leeuwenhoek while observing the protozoans. In lower organisms, these appendages are responsible for cell movement, while in higher organisms, these appendages help in the movement of the extracellular fluids within the body cavities.
The cilia are made up of microtubules in a 9+2 arrangement, with nine microtubule doublet ring bundles, surrounding a pair of central singlet microtubule bundles. The doublet microtubule bundles are...
Mechanism of Ciliary Motion01:05

Mechanism of Ciliary Motion

The ciliary structures were first seen in 1647 by Antonie Leeuwenhoek while observing the protozoans. In lower organisms, these appendages are responsible for cell movement, while in higher organisms, these appendages help in the movement of the extracellular fluids within the body cavities.
The cilia are made up of microtubules in a 9+2 arrangement, with nine microtubule doublet ring bundles, surrounding a pair of central singlet microtubule bundles. The doublet microtubule bundles are...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...